Order Article Reprints

Song Q, Wang H, Jiang D, Xu C, Cui J, Zhang Q, Wang H, Huang J, Su J, Wu GS, et al. Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC). Cancers. 2021; 13(19):4766. https://doi.org/10.3390/cancers13194766

Song, Qi, Herui Wang, Dongxian Jiang, Chen Xu, Jing Cui, Qi Zhang, Haixing Wang, Jie Huang, Jieakesu Su, Gen Sheng Wu, and et al. 2021. "Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)" Cancers 13, no. 19: 4766. https://doi.org/10.3390/cancers13194766

Song, Q., Wang, H., Jiang, D., Xu, C., Cui, J., Zhang, Q., Wang, H., Huang, J., Su, J., Wu, G. S., Zhuang, Z., & Hou, Y. (2021). Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC). Cancers, 13(19), 4766. https://doi.org/10.3390/cancers13194766